Insider Shareholders with Direct Ownership of Intellia Therapeutics, Inc. (NTLA)
This section provides a comprehensive overview of the insiders with direct ownership of Intellia Therapeutics, Inc. (NTLA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Intellia Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Novartis Institutes For Bio Medical Research, Inc.
> 10% Shareholder |
5,652,903 | 1,523,000 | 4,129,903 $81.4 Million | 3 |
Dec 12, 2017
Reduced 26.94%
|
John M Leonard
President and CEO |
1,125,480 | 632,760 | 960,072 $18.9 Million | 42 |
Mar 01, 2024
Added 10.58%
|
Jose E Rivera
EVP, General Counsel |
263,203 | 137,677 | 162,388 $3.2 Million | 18 |
Apr 01, 2021
Reduced 0.08%
|
David Lebwohl
EVP, Chief Medical Officer |
112,675 | 21,468 | 93,073 $1.84 Million | 20 |
Mar 01, 2024
Added 29.37%
|
Laura Sepp Lorenzino
EVP, Chief Scientific Officer |
215,220 | 136,793 | 81,893 $1.61 Million | 15 |
Mar 01, 2024
Added 31.68%
|
James Basta
EVP, General Counsel |
89,899 | 8,328 | 81,571 $1.61 Million | 7 |
Mar 04, 2024
Reduced 2.74%
|
Eliana Clark
EVP, Chief Technical Officer |
77,430 | 13,006 | 71,470 $1.41 Million | 12 |
Jul 01, 2024
Reduced 0.56%
|
Glenn Goddard
EVP, Chief Financial Officer |
131,500 | 62,287 | 69,213 $1.36 Million | 17 |
Mar 01, 2024
Added 29.26%
|
Derek Hicks
EVP, Chief Business Officer |
72,069 | 5,689 | 66,380 $1.31 Million | 5 |
Mar 01, 2024
Added 30.69%
|
Edward J Dulac Iii
EVP, Chief Financial Officer |
66,324 | 0 | 66,324 $1.31 Million | 1 |
Jul 22, 2024
Added 50.0%
|
39,453 | 0 | 49,453 $975,213 | 5 |
Jun 12, 2024
Added 13.53%
|
|
Michael P Dube
VP, PAO and Interim PFO |
17,801 | 0 | 49,024 $966,753 | 1 |
Jul 01, 2024
Added 26.64%
|
19,893 | 0 | 26,693 $526,385 | 3 |
Jun 12, 2024
Added 22.47%
|
|
24,408 | 0 | 23,883 $470,972 | 5 |
Jun 12, 2024
Added 24.47%
|
|
22,130 | 2,397 | 19,733 $389,134 | 7 |
Jun 12, 2024
Added 28.17%
|
|
19,453 | 0 | 19,453 $383,613 | 4 |
Jun 12, 2024
Added 28.46%
|
|
19,453 | 1,505 | 17,948 $353,934 | 5 |
Jun 17, 2024
Reduced 7.74%
|
|
Andrew Schiermeier
EVP, Chief Operating Officer |
6,292 | 1,377 | 16,656 $328,456 | 3 |
Jan 05, 2021
Reduced 7.64%
|
15,409 | 0 | 15,409 $303,865 | 1 |
Jun 13, 2024
Added 50.0%
|
|
Caroline Dorsa
Director |
14,791 | 7,500 | 12,701 $250,463 | 4 |
Jun 14, 2022
Added 29.04%
|
John F Crowley
Director |
24,216 | 12,500 | 11,716 $231,039 | 7 |
Jun 14, 2023
Added 27.41%
|
Jean Francois Formela
Director |
7,291 | 0 | 7,291 $143,778 | 2 |
Jun 14, 2022
Added 41.62%
|
Perry A Karsen
Director |
88,764 | 88,764 | 5,000 $98,600 | 2 |
Dec 17, 2020
Reduced 81.01%
|